755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome

Background and Objective Basal Cell Nevus syndrome (BCNS) is characterized by numerous basal cell carcinomas (BCCs). Multiple treatments with the pulsed dye laser (PDL) have been shown, in small studies, to be effective for the treatment of superficial and nodular BCCs. Like PDL, the alexandrite las...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Tannous, Zeina (author)
مؤلفون آخرون: Ibrahimi, Omar A. (author), Sakamoto, Fernanda H. (author), Anderson, Rox R. (author)
التنسيق: article
منشور في: 2011
الوصول للمادة أونلاين:http://hdl.handle.net/10725/6565
http://dx.doi.org/10.1002/lsm.20953
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://onlinelibrary.wiley.com/doi/10.1002/lsm.20953/full
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513480251408384
author Tannous, Zeina
author2 Ibrahimi, Omar A.
Sakamoto, Fernanda H.
Anderson, Rox R.
author2_role author
author
author
author_facet Tannous, Zeina
Ibrahimi, Omar A.
Sakamoto, Fernanda H.
Anderson, Rox R.
author_role author
dc.creator.none.fl_str_mv Tannous, Zeina
Ibrahimi, Omar A.
Sakamoto, Fernanda H.
Anderson, Rox R.
dc.date.none.fl_str_mv 2011
2017-11-08T13:27:42Z
2017-11-08T13:27:42Z
2017-11-08
dc.identifier.none.fl_str_mv 1096-9101
http://hdl.handle.net/10725/6565
http://dx.doi.org/10.1002/lsm.20953
Ibrahimi, O. A., Sakamoto, F. H., Tannous, Z., & Anderson, R. (2011). 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome. Lasers in surgery and medicine, 43(2), 68-71.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://onlinelibrary.wiley.com/doi/10.1002/lsm.20953/full
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Lasers in Surgery and Medicine
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Background and Objective Basal Cell Nevus syndrome (BCNS) is characterized by numerous basal cell carcinomas (BCCs). Multiple treatments with the pulsed dye laser (PDL) have been shown, in small studies, to be effective for the treatment of superficial and nodular BCCs. Like PDL, the alexandrite laser can be vessel-selective, but has the added advantage of deeper tissue penetration. We evaluated the utility of the alexandrite laser in reducing the tumor burden in BCNS with a single treatment. Study Design/Materials and Methods A case report and review of the literature are presented. A 45-year-old man with BCNS and a history of radiation therapy presented with an extraordinarily high tumor burden (>250 BCCs). As a compassionate measure to reduce the tumor burden, we investigated the utility of a single treatment of the long-pulsed 755 nm alexandrite laser to several BCC lesions. The treated lesions were evaluated at 2-month and 7-month clinical follow-up. Histopathologic analysis of a treated lesion was performed at 7-month clinical follow-up. Results At 2-month, and 7-month clinical follow-up, 15 of 18 treated lesions or about 83% of the alexandrite laser treated lesions showed a complete clinical response and appeared as hypopigmented areas with scarring. Histopathologic analysis of a treated lesion at 7-month clinical follow-up showed no evidence of residual tumor. Conclusions The long-pulsed alexandrite laser may be helpful in significantly reducing tumor burden in difficult to manage BCNS patients with a single treatment. This provides a facile and practical treatment alternative for the management of challenging cases of BCNS. The limitation of this study is that it is a single case observation. Larger, prospective studies are needed to confirm these observations. Lasers Surg. Med. 42:68–71, 2011 © 2011 Wiley-Liss, Inc
eu_rights_str_mv openAccess
format article
id LAURepo_e874bfff7bc63fcfe0dbc13401043bcc
identifier_str_mv 1096-9101
Ibrahimi, O. A., Sakamoto, F. H., Tannous, Z., & Anderson, R. (2011). 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome. Lasers in surgery and medicine, 43(2), 68-71.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/6565
publishDate 2011
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndromeTannous, ZeinaIbrahimi, Omar A.Sakamoto, Fernanda H.Anderson, Rox R.Background and Objective Basal Cell Nevus syndrome (BCNS) is characterized by numerous basal cell carcinomas (BCCs). Multiple treatments with the pulsed dye laser (PDL) have been shown, in small studies, to be effective for the treatment of superficial and nodular BCCs. Like PDL, the alexandrite laser can be vessel-selective, but has the added advantage of deeper tissue penetration. We evaluated the utility of the alexandrite laser in reducing the tumor burden in BCNS with a single treatment. Study Design/Materials and Methods A case report and review of the literature are presented. A 45-year-old man with BCNS and a history of radiation therapy presented with an extraordinarily high tumor burden (>250 BCCs). As a compassionate measure to reduce the tumor burden, we investigated the utility of a single treatment of the long-pulsed 755 nm alexandrite laser to several BCC lesions. The treated lesions were evaluated at 2-month and 7-month clinical follow-up. Histopathologic analysis of a treated lesion was performed at 7-month clinical follow-up. Results At 2-month, and 7-month clinical follow-up, 15 of 18 treated lesions or about 83% of the alexandrite laser treated lesions showed a complete clinical response and appeared as hypopigmented areas with scarring. Histopathologic analysis of a treated lesion at 7-month clinical follow-up showed no evidence of residual tumor. Conclusions The long-pulsed alexandrite laser may be helpful in significantly reducing tumor burden in difficult to manage BCNS patients with a single treatment. This provides a facile and practical treatment alternative for the management of challenging cases of BCNS. The limitation of this study is that it is a single case observation. Larger, prospective studies are needed to confirm these observations. Lasers Surg. Med. 42:68–71, 2011 © 2011 Wiley-Liss, IncPublishedN/A2017-11-08T13:27:42Z2017-11-08T13:27:42Z20112017-11-08Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1096-9101http://hdl.handle.net/10725/6565http://dx.doi.org/10.1002/lsm.20953Ibrahimi, O. A., Sakamoto, F. H., Tannous, Z., & Anderson, R. (2011). 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome. Lasers in surgery and medicine, 43(2), 68-71.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://onlinelibrary.wiley.com/doi/10.1002/lsm.20953/fullenLasers in Surgery and Medicineinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/65652021-03-19T10:03:27Z
spellingShingle 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
Tannous, Zeina
status_str publishedVersion
title 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
title_full 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
title_fullStr 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
title_full_unstemmed 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
title_short 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
title_sort 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome
url http://hdl.handle.net/10725/6565
http://dx.doi.org/10.1002/lsm.20953
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://onlinelibrary.wiley.com/doi/10.1002/lsm.20953/full